Journal metric profile

TRANSFUSION MEDICINE AND HEMOTHERAPY

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 1.900 2025 metric year
5-Year Impact Factor 2.600 Longer citation window
JCR Quartile Q3 Subject-category quartile
JCR Category Rank 62/98 Recorded category rank

TRANSFUSION MEDICINE AND HEMOTHERAPY JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

TRANSFUSION MEDICINE AND HEMOTHERAPY metric snapshot

TRANSFUSION MEDICINE AND HEMOTHERAPY has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is KARGER. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 1.900. The five-year Journal Impact Factor is 2.600, giving a second citation window for comparison. The journal is recorded in quartile Q3 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 62 out of 98 journals. Based on that rank position, the journal sits within approximately the top 63% of the listed category. Its listed quartile is Q3. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (2.600) is 0.700 points higher than the standard Journal Impact Factor (1.900). Without journal self-citations, the Impact Factor is 1.800, a difference of 0.100 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 0.390. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for TRANSFUSION MEDICINE AND HEMOTHERAPY lists total cites: 1,656; total articles: 29; citable items: 43. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 7.7 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 7.5 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

TRANSFUSION MEDICINE AND HEMOTHERAPY is identified in this directory by print ISSN 1660-3796 and electronic ISSN 1660-3818. The publisher is recorded as KARGER. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameTRANSFUSION MEDICINE AND HEMOTHERAPY
Abbreviated journalTRANSFUS MED HEMOTH
PublisherKARGER
Metric year2025
Overall rank8,733
ISSN1660-3796
eISSN1660-3818
Total cites1,656
Total articles29
Citable items43
Cited half-life7.7 years
Citing half-life7.5 years
JCR-based Journal Impact Factor1.900
5-Year Impact Factor2.600
Impact Factor without journal self-cites1.800
Journal Citation Indicator0.390
JCR Impact Factor quartileQ3
JCR category rank62/98
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of TRANSFUSION MEDICINE AND HEMOTHERAPY?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for TRANSFUSION MEDICINE AND HEMOTHERAPY is 1.900 for the 2025 metric year.

What are the JCR quartile and category rank of TRANSFUSION MEDICINE AND HEMOTHERAPY?

TRANSFUSION MEDICINE AND HEMOTHERAPY is listed with quartile Q3 and category rank 62/98. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of TRANSFUSION MEDICINE AND HEMOTHERAPY?

The five-year Journal Impact Factor recorded for TRANSFUSION MEDICINE AND HEMOTHERAPY is 2.600. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes TRANSFUSION MEDICINE AND HEMOTHERAPY?

TRANSFUSION MEDICINE AND HEMOTHERAPY is listed in this directory as being published by KARGER.

Additional records from the same publisher or with a similar listed JCR Impact Factor.